OS-01 Peptide Topical Formulation Improves Skin Barrier Function and Reduces Systemic Inflammation Markers: A Pilot 12-Week Clinical Trial.

J Cosmet Dermatol · 2025 · PMC11975214 · PMID 40193112

Europe PMC DOI

hedged sentence

0.0750

closest p · 1.5× alpha

0.0750

boldest claim

The sentences

close to significancep = 0.075so close (0.05 < p ≤ 0.1)

Direct comparisons of the hydration improvement between participants in the control and OS‐01 groups reveal a significant enhancement in the hydration of the upper arm ( p = 0.022) and close to significance in the forearm ( p = 0.075) on the subjects using the OS‐01 formulation.

also in 705 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.